SDGR: Schrödinger, Inc. Stock

by  •  • Comments Off on SDGR: Schrödinger, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,214.66
Enterprise Value ($M) 1,054.24
Book Value ($M) 449.43
Book Value / Share 7.06
Price / Book 2.70
NCAV ($M) 236.53
NCAV / Share 3.71
Price / NCAV 5.14

Profitability (mra)
Return on Invested Capital (ROIC) -0.31
Return on Assets (ROA) -0.22
Return on Equity (ROE) -0.32

Liquidity (mrq)
Quick Ratio 4.11
Current Ratio 4.11

Balance Sheet (mrq) ($M)
Current Assets 456.40
Assets 669.30
Liabilities 219.87
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-13 13G Rubric Capital Management LP 5.79
02-13 13G/A Vanguard Group Inc 10.78 1.60
01-23 13G/A BlackRock, Inc. 13.90 3.85

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-07-31 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-02-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-15 40,784 395,842 10.30
2025-01-14 129,957 571,191 22.75
2025-01-13 119,891 507,216 23.64
2025-01-10 88,628 398,696 22.23

(click for more detail)

Similar Companies
RXRX – Recursion Pharmaceuticals, Inc. SANA – Sana Biotechnology, Inc.
SCPH – scPharmaceuticals Inc. SLDB – Solid Biosciences Inc.
SLRN – Acelyrin, Inc.


Financial data and stock pages provided by
Fintel.io